Analyst firms · Bernstein · AGL
Bernstein AGL price target and rating history
agilon health inc. (AGL) · Health Care
Bernstein rates agilon health inc. (AGL) Outperform with a $125 price target, as of its latest action on Sep 15, 2026. It has published 4 rating actions on AGL since December 2024, including 2 upgrades and 1 downgrade. Across 5 firms with a AGL price target in the last 12 months, the median target is $81. Bernstein's $125 is 54% above that.
- Current rating
- Outperform
- Price target
- $125
- Median target, all firms
- $81
- Actions on AGL
- 4
Bernstein price target on AGL
Every Bernstein rating on AGL
- Sep 15, 2026
- Aug 20, 2025
- Apr 8, 2025
- Dec 11, 2024
How other firms rate AGL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Bernstein | Outperform | $125 | Sep 15, 2026 |
| Citigroup | Neutral | $115 | Aug 11, 2026 |
| Barclays | Equal Weight | $81 | May 26, 2026 |
| Jefferies | Buy | $48 | May 7, 2026 |
| Deutsche Bank | Buy | $49 | May 7, 2026 |
Questions about Bernstein and AGL
- What is Bernstein's price target for AGL?
- Bernstein's latest stated price target for agilon health inc. (AGL) is $125, from its action on Sep 15, 2026.
- What is Bernstein's rating on AGL?
- Bernstein rates AGL Outperform, a bullish rating, as of Sep 15, 2026.
- When did Bernstein last change its view on AGL?
- On Sep 15, 2026, Bernstein upgrades to Outperform from Mkt Perform, price target $125.
- How does Bernstein's AGL target compare with other analysts?
- Across 5 firms with a AGL price target in the last 12 months, the median target is $81. Bernstein's $125 is 54% above that.
More AGL rating histories
All Bernstein ratingsAGL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.